Treace Medical Concepts TMCI
NASDAQ TMCI
$4.35 -0.21 (-4.61%)
At close: Aug 20, 2026 · 1:15 PM UTC

Treace Medical Concepts (TMCI) EBIT Margin Growth (1y) (2021 - 2026)

Treace Medical Concepts (TMCI) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn -497.00
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 670.00
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 301.00
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn 546.00
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 264.00
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn 595.00
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn 89.00
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -247.00
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 146.00
10 Treace Medical Concepts 282.97 Mn 237.35 Mn 35.61 Mn 286.00

Historic Data

Download Data
DateValue
Jun 30, 2026 286.00
Mar 31, 2026 -673.00
Dec 31, 2025 -918.00
Sep 30, 2025 235.00
Jun 30, 2025 1,228.00
Mar 31, 2025 747.00
Dec 31, 2024 1,060.00
Sep 30, 2024 1,015.00
Jun 30, 2024 -1,699.00
Mar 31, 2024 -447.00
Dec 31, 2023 -387.00
Sep 30, 2023 -948.00
Jun 30, 2023 871.00
Mar 31, 2023 -478.00
Dec 31, 2022 971.00
Sep 30, 2022 -898.00
Jun 30, 2022 -2,021.00
Mar 31, 2022 -2,038.00
Dec 31, 2021 -3,182.00
Sep 30, 2021 -2,481.00